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u Wang, MD, PHD,* Michael Jerosch-Herold, PHD,†‡ David R. Jacobs, JR, PHD,*§
yal Shahar, MD, MPH,* Aaron R. Folsom, MD, MPH*
inneapolis, Minnesota; Portland, Oregon; and Oslo, Norway
OBJECTIVES The purpose of this study was to determine the cross-sectional relation between myocardial
perfusion and coronary heart disease (CHD) risk factors among adults with no clinical CHD.
BACKGROUND Clinical studies suggest that myocardial perfusion is often abnormal in individuals without
CHD but with risk factors. Epidemiologic study in asymptomatic populations is lacking.
METHODS Two hundred twenty-two men and women, ages 45 to 84 years and free of a CHD diagnosis,
in the University of Minnesota field center of the Multi-Ethnic Study of Atherosclerosis
(MESA) had myocardial blood flow (MBF) determined using cardiac magnetic resonance
imaging at rest and during adenosine-induced hyperemia. Perfusion reserve (PR) was
calculated as the ratio of hyperemic to rest MBF.
RESULTS Both resting and hyperemic MBF were lower in men than in women, even after considering
age and menopause. Hyperemic MBF was also significantly lower in subjects who were older,
and in those with higher blood pressure, higher fasting glucose, and lower low-density
lipoprotein cholesterol. After adjusting for age, gender, and race, reduced PR was indepen-
dently associated with hypertension, higher diastolic blood pressure, and higher total and
low-density lipoprotein cholesterol, but was not associated with cigarette smoking, obesity,
physical activity, or diabetes. Moreover, hyperemic MBF and PR were correlated strongly and
inversely with estimated 10-year CHD risk based on Framingham equations (p for trends:
0.0001).
CONCLUSIONS Coronary vasoreactivity is reduced in asymptomatic individuals with a greater coronary risk
factor burden. Our study results imply that changes in coronary vascular reactivity, in response
to risk factors, may be detected in adults without symptomatic CHD. (J Am Coll Cardiol
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.09.0362006;47:565–72) © 2006 by the American College of Cardiology Foundation
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wyocardial blood flow (MBF) can be quantitatively mea-
ured by noninvasive imaging of the transit of intravenously
njected contrast agents through the myocardium. The
aximal MBF achieved during hyperemia, compared to
BF at rest, reflects the capacity of the coronary vasculature
o self-regulate vasomotion. Clinical studies suggest that
BF is often abnormal in individuals without evidence of
oronary heart disease (CHD) but with risk factors (1–10),
nd the coronary flow reserve can be improved with lifestyle
odifications or pharmacological intervention (11–13).
owever, the association between MBF and CHD risk
actors has not been investigated in population-based stud-
es of asymptomatic adults.
The objective of this study was to determine the cross-
ectional relation between myocardial perfusion, studied
From the *Division of Epidemiology, School of Public Health and the †Depart-
ent of Radiology, School of Medicine, University of Minnesota, Minneapolis,
innesota; ‡Advanced Imaging Research Center, Oregon Health & Science Uni-
ersity, Portland, Oregon; and the §Department of Nutrition, University of Oslo,
slo, Norway. Supported by grant R01 HL-65580 and contracts N01-HC-95159
hrough N01-HC-95169 (MESA) from the National Heart, Lung, and Blood
nstitute, National Institutes of Health.H
Manuscript received May 20, 2005; revised manuscript received September 5, 2005,
ccepted September 19, 2005.ith a validated cardiac magnetic resonance imaging
CMR) technique at rest and during adenosine-induced
yperemia, and CHD risk factors in asymptomatic individ-
als. We hypothesized that perfusion reserve (PR), calcu-
ated as the ratio of hyperemic MBF to resting MBF, is
nversely associated with levels of CHD risk factors.
ETHODS
tudy subjects. Subjects were recruited from participants
n the University of Minnesota field center of the Multi-
thnic Study of Atherosclerosis (MESA), a population-
ased prospective cohort study of subclinical cardiovascular
isease and its progression (14). All participants in the
ESA study reported no previous history of CHD. Each
ohort member at the MESA Minnesota Field Center was
ontacted for a perfusion study, either immediately after the
aseline MESA clinic exam or later, by mail. Two hundred
hirty-four of the 1,066 cohort members finally consented to
e examined for myocardial perfusion, a mean of nine
onths (range: 0.5 to 33 months) after their first MESA
linic exams in 2000 to 2002. Members of this sub-cohort
ere 45 to 84 years old; 57% were Caucasian (the remainder
ispanic) and 57% were male, which is similar to the entire
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Coronary Risk Factors and Myocardial Perfusion February 2006:565–72ESA Minnesota cohort. Subjects who participated in the
erfusion study were comparable to those who did not on
ost standard risk factors, but had a significantly (p 0.05)
maller body mass index (28.7 vs. 29.5 kg/m2) and a lower
revalence of hypertension (21% vs. 33%).
R image acquisition. Participants were asked to abstain
rom caffeine intake for 12 h before their CMR exam.
ardiac magnetic resonance imaging was performed with a
.5-T clinical magnetic resonance scanner (Sonata, Siemens
edical Systems, Iselin, New Jersey) at the Fairview-
niversity of Minnesota hospital. The participant was
ositioned supine with an intravenous (IV) needle inserted
nto an antecubital vein for injection of MR contrast and
nfusion of adenosine. A flexible, four-element phased array
oil was placed on the participant’s chest at the level of the
eart; two elements of a spine array coil integrated into the
atient table were used as posterior coil elements. Scout
agnetic resonance images were acquired first, to determine
he orientation of the long and short axis of the left
entricle. Blood pressure, heart rate, and the electrocardio-
ram were monitored and recorded during the CMR
xamination. Rate-pressure product (RPP), at rest and
yperemia, was calculated as the product of heart rate (in
eats/min) multiplied by systolic blood pressure (in mm Hg)
uring the scan and divided by 10,000.
We conducted T1-weighted imaging with a fast gradient
cho sequence for two to three slices in a short-axis
rientation (slice thickness: 8 mm) to track the first pass of
n injected contrast agent bolus through the right and left
entricle and its recirculation. A Gd-DTPA bolus (Magne-
ist, Berlex, Wayne, New Jersey) of 0.04 mmol per kg of
ody weight (total volume mean  SD: 6.5  1.2 ml) was
njected, starting at the third or fourth heartbeat, with a
ower injector at a rate of 7 ml/s, followed by a saline flush
f 10 ml at the same injection rate. All slices were imaged
uring each heartbeat, for a total of 50 heart beats. The
umber of slices was adjusted to two or three to meet the
verriding priority of achieving a temporal resolution equiv-
lent to each participant’s R-to-R duration. A first perfusion
Abbreviations and Acronyms
ANOVA  analysis of variance
AV  atrial-ventricular
BMI  body mass index
CHD  coronary heart disease
CMR  cardiac magnetic resonance imaging
HDL  high-density lipoprotein
IV  intravenous
LDL  low-density lipoprotein
MBF  myocardial blood flow
MESA  Multi-Ethnic Study of Atherosclerosis
PR  perfusion reserve
RPP  rate-pressure product
SI  signal intensitycan was performed during rest, followed by a second scan obout 15 min later during maximal vasodilation. Vasodila-
ion was induced by intravenous infusion of adenosine: 0.14
g/kg/min for 3 min before start of the scan, blocked for
pproximately 3 s during MR contrast injection, and re-
umed immediately thereafter. The adenosine infusion was
ot completely turned off until acquisition of the first 10 to
5 images. Brief, asymptomatic atrial-ventricular (AV)
locks (duration 5 s) were observed in 43 cases, all of
hich occurred after the contrast bolus injection, and
denosine had already been infused for an initial 3 min. The
V blocks resolved within a few seconds after the adenosine
nfusion was stopped. The perfusion scans were completed,
nd hyperemic MBF was determined in all cases where
denosine infusion was prematurely terminated. All MBF
easurements were used in statistical analyses. Repeated
nalyses eliminating those participants who had a brief AV
lock yielded relatively weaker results.
mage analysis and MBF quantification. Endocardial and
picardial contours were manually traced. The myocardium
as subdivided into eight transmural sectors of equal
ircumferential extent along the myocardial centerline.
egion-of-interest signal intensity (SI) curves were gener-
ted with the MASS CMR image analysis software (Lab-
ratory for Clinical and Experimental Image Processing,
eiden University, Leiden, the Netherlands). Signal inten-
ity curves represent the change of mean SI in each
yocardial sector as a function of time. The mean SI before
ppearance of the contrast agent in the left ventricle was
ubtracted for baseline correction of each signal curve. In
ccordance with the central volume principle (15), MBF
as estimated from the initial amplitude of the myocardial
mpulse response by deconvolution analysis of the myocar-
ial SI curves. To perform a model-independent deconvo-
ution of the SI curves, custom-written software was used
ith an arterial input measured in the center of the left
entricle (16,17). Perfusion reserve was calculated as the ratio
f MBF during hyperemia to rest. Since no focal perfusion
efect was observed in any participant, all measurements
eported in the present study are global averages over the eight
yocardial segments and two to three slices.
easurement of risk factors. Risk factors were measured
t the MESA clinic using standardized methods. “Ever
moking” was defined as lifetime consumption of more than
00 cigarettes. “Current smoking” was defined as smoking
igarettes within the past 30 days. “Former smoking” was
efined as ever but not current smoking. Level of physical
ctivity was computed by multiplying total time of activity
er week by activity intensity values. Height and weight
ere measured, and body mass index (BMI, kg/m2) was
ssessed. Resting seated blood pressure was measured three
imes using an automated oscillometric sphygmomanome-
er, and the average of the last two measurements was used
or analysis (called “clinic blood pressure”). Hypertension
as defined as systolic blood pressure 140 mm Hg,
iastolic blood pressure 90 mm Hg, self-reported history
f hypertension, or current use of antihypertensive medica-
t
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February 2006:565–72 Coronary Risk Factors and Myocardial Perfusionions. Blood samples were obtained from participants after
h of fasting and analyzed at a central laboratory for glucose,
otal cholesterol, low-density lipoprotein (LDL) cholesterol,
nd high-density lipoprotein (HDL) cholesterol. Diabetes
ellitus was defined as fasting glucose 126 mg/dl, self-
eported history of diabetes, or taking diabetes medications.
tatistical analysis. Participants were excluded from sta-
istical analysis if they had missing values on any one of the
ajor perfusion measurements (resting MBF, hyperemic
BF or PR, n 5), or they took caffeine within 12 h before
MR scanning (n 7). Analysis was performed using SAS
oftware (SAS Institute, Cary, North Carolina), version 8.
he perfusion and hemodynamic measurements were com-
ared across categories of risk factors using t tests or analysis
f variance (ANOVA). Pearson correlation coefficients were
alculated between continuous risk factors and perfusion
easurements. Linear regression analysis was performed to
stimate the difference in MBF and PR predicted by a given
ifference in risk factor, including, if needed, a quadratic term
or continuous variables to test the curvilinear trend. Because of
otential concerns with the statistical properties of PR mea-
ured as a ratio (18,19), we also modeled absolute hyperemic
BF with adjustment for resting MBF as an alternative
resentation of PR. Each risk factor was first modeled sepa-
ately, adjusting only for demographic factors such as age,
ender, and race. Afterwards, all the major risk factors,
ncluding cigarette smoking habit, BMI, physical activity,
ypertension, diabetes, and blood lipids, were entered
imultaneously. Finally, to evaluate the joint effect of risk
actors on perfusion, 10-year risk of CHD was estimated
sing the Framingham risk scoring method (20). Perfusion
easures were compared across categories of absolute and
elative CHD risk using ANOVA. A value of p  0.05
two-sided) was considered to indicate statistical significance.
ESULTS
uring the rest phase of the perfusion study, the 222
articipants had a mean  SD heart rate of 69  11
eats/min, systolic blood pressure of 133 19 mm Hg, and
iastolic blood pressure of 79  10 mm Hg. Global resting
BF averaged 1.01  0.23 ml/g/min (range: 0.54 to 1.82
l/g/min) and was correlated positively with resting RPP
r  0.57, p  0.0001). Resting RPP was progressively
igher with increasing age, BMI, clinic blood pressure,
lycemia, and total cholesterol (Table 1). Resting MBF
ended to be higher for participants with these same
haracteristics, except glycemia. Resting MBF was also
igher in women and in participants with higher HDL
holesterol.
In the participants without AV block, the following
emodynamic parameters changed significantly during hy-
eremia compared to baseline: diastolic blood pressure
ecreased by 0.54 mm Hg, systolic blood pressure decreased
y 5.2 mm Hg, and heart rate increased by 17 beats/min. In
he subgroup of participants with AV block, the hemody- samic changes were milder but still statistically significant,
xcept for systolic blood pressure. Overall, hyperemia raised
PP only slightly (from 0.91 to 1.09, p  0.0001), but
ccompanied by a three-fold increase of MBF to 3.02 
.84 ml/g/min (range: 0.98 to 5.63). The MBF increase was
ven greater in participants with AV block compared to
hose with normal response to adenosine, possibly because
f the increase in heart rate by 10 to 30 beats after a brief
V block. The correlation between MBF and RPP under
yperemia (r  0.28, p  0.0001) was weaker than that at
est. Hyperemic RPP did not differ by most risk factors,
xcept for gender and BMI (Table 1). Women continued to
ave significantly higher MBF than men during hyperemia,
hereas subjects who were older, had higher clinic blood
ressure and blood glucose, and had lower HDL choles-
erol, had significantly lower hyperemic MBF.
Perfusion reserve ranged from 1.18 to 5.24 (mean  SD:
.05  0.84). Perfusion reserve was significantly lower
mong male participants, those at older ages, and those with
ypertension and higher levels of fasting glucose, total
holesterol, and LDL cholesterol (Table 1). Age demon-
trated the strongest and most significant correlation with
R (r   0.36, p  0.0001), followed by clinic systolic
lood pressure (r  0.24, p  0.0003), diastolic blood
ressure (r  0.21, p  0.002), fasting glucose (r 
0.16, p  0.02), total cholesterol (r  0.14, p  0.04),
nd LDL cholesterol (r  0.12, p  0.07). Other risk
actors did not show significant correlations with PR. After
djusting for age, gender, and race, participants who had
ne unit higher diastolic blood pressure, total cholesterol,
nd LDL cholesterol had lower hyperemic MBF by 0.0099,
.0028, and 0.0025 ml/g/min, respectively, and lower PR by
.013, 0.0044, and 0.0039, respectively (Table 2). Subjects
ith prevalent hypertension had 0.30 lower PR than did
hose without hypertension. In the multivariate adjusted
odel, the inverse relation of PR with hypertension and
lood cholesterol remained statistically significant even after
djusting for all the other traditional risk factors simulta-
eously (Table 3). Stratified analysis revealed that the
ssociations were relatively stronger in the middle-aged
articipants (45 to 64 years) compared to older participants
65 years), but did not differ by gender or medication use.
The mean  SD predicted 10-year absolute risk of total
HD, estimated from the Framingham prediction equation
20), was 11  8% in this cohort. The predicted absolute
HD risk (Fig. 1) was inversely associated with hyperemic
BF (p for trend: 0.0001) and PR (p for trend:
0.0001). The prevalence of reduced PR (2.5) was
rogressively higher (16%, 20%, 36%, and 53%, p for trend
0.0001) across increasing quartiles of predicted absolute
HD risk. When the excessive risk conferred by age and
ender alone was considered, the predicted relative CHD
isk had an inverse relation with hyperemic MBF and PR,
imilar to that for absolute risk (data not shown).
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Coronary Risk Factors and Myocardial Perfusion February 2006:565–72able 1. Unadjusted Mean Perfusion Measurements and Hemodynamic Parameters Across Categories of Participant Characteristics
Risk Factors N
At Rest During Hyperemia
Perfusion
Reserve
RPP
(beats/min mm Hg)
MBF
(ml/g/min)
RPP
(beats/min mm Hg)
MBF
(ml/g/min)
ge (yrs)
45–54 80 0.85 0.97 1.08 3.28 3.47
55–64 65 0.92 1.06 1.09 2.97 2.85
65–74 51 0.97 1.01 1.11 2.82 2.85
75–84 26 0.98 1.05 1.07 2.71 2.59
p for overall difference 0.002 0.07 0.90 0.002 0.0001
ender
Women 97 0.92 1.12 1.13 3.48 3.20
Men 125 0.90 0.93 1.06 2.66 2.94
p for t test 0.53 0.0001 0.07 0.0001 0.02
ace
Caucasian 126 0.92 1.02 1.09 3.01 3.04
Hispanic 96 0.90 1.01 1.08 3.04 3.07
p for t test 0.66 0.92 0.69 0.79 0.82
igarette smoking
Never 87 0.94 1.04 1.12 3.05 3.02
Former 98 0.89 0.99 1.06 2.97 3.06
Current 36 0.88 1.01 1.09 3.11 3.14
p for overall difference 0.19 0.47 0.35 0.68 0.77
ody mass index (kg/m2)
25 49 0.86 0.99 1.07 3.07 3.18
25–29.99 87 0.89 0.99 1.05 2.96 3.05
30 86 0.95 1.05 1.14 3.05 2.98
p for overall difference 0.03 0.24 0.07 0.68 0.44
hysical activity (min/week · MET)
1st tertile: 3,500 73 0.94 1.04 1.09 2.95 2.90
2nd tertile: 3,500–6,600 75 0.91 1.02 1.12 3.12 3.12
3rd tertile: 6,600 74 0.89 0.98 1.06 2.99 3.13
p for overall difference 0.31 0.32 0.34 0.45 0.19
ypertension
No 168 0.89 1.00 1.08 3.07 3.15
Yes 54 0.97 1.06 1.10 2.88 2.73
p for t test 0.01 0.11 0.74 0.15 0.001
ystolic blood pressure (mm Hg)
120 114 0.86 0.99 1.06 3.14 3.25
120–139 79 0.95 1.03 1.12 2.91 2.90
140 29 1.01 1.06 1.13 2.85 2.69
p for overall difference 0.0001 0.34 0.17 0.08 0.0008
iastolic blood pressure (mm Hg)
75 155 0.90 1.04 1.08 3.18 3.14
75–89 60 0.93 0.96 1.09 2.73 2.93
90 7 1.07 0.97 1.19 2.10 2.10
p for overall difference 0.07 0.07 0.57 0.0001 0.003
iabetes
No 198 0.90 1.01 1.08 3.04 3.08
Yes 24 1.00 1.03 1.14 2.85 2.82
p for t test 0.03 0.75 0.35 0.28 0.15
asting glucose (mg/dl)
96 110 0.88 1.03 1.07 3.18 3.17
96–125 95 0.93 1.00 1.09 2.88 2.96
126 17 1.02 1.03 1.21 2.80 2.76
p for overall difference 0.01 0.64 0.12 0.02 0.06
otal cholesterol (mg/dl)
200 127 0.90 0.98 1.08 3.08 3.21
200–239 78 0.91 1.06 1.07 2.93 2.84
240 17 0.98 1.08 1.20 2.99 2.83
p for overall difference 0.33 0.04 0.22 0.44 0.005
DL cholesterol (mg/dl)
130 151 0.90 1.01 1.07 3.10 3.15
130–159 49 0.95 1.02 1.15 2.85 2.83
160 19 0.88 1.02 1.10 2.81 2.80
p for overall difference 0.26 0.91 0.20 0.11 0.03
DL cholesterol (mg/dl)
60 43 0.94 1.08 1.10 3.04 2.90
40–59 110 0.89 1.03 1.09 3.21 3.19
40 69 0.92 0.95 1.07 2.71 2.92
p for overall difference 0.32 0.009 0.86 0.0004 0.05
DL  high-density lipoprotein; LDL  low-density lipoprotein; MBF  myocardial blood flow; RPP  rate-pressure product.
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February 2006:565–72 Coronary Risk Factors and Myocardial PerfusionISCUSSION
ur study shows that the coronary vasodilatory response in
erms of hyperemic MBF and PR correlate inversely with
HD risk factor burden, as assessed by Framingham
rediction equations, in asymptomatic middle-aged and
lder adults. The associations vary and tend to be weak with
espect to individual risk factors. To our knowledge, this is
he first population-based study of MBF under rest and
tress conditions in asymptomatic individuals.
Myocardial perfusion imaging examination was originally
esigned to assess the hemodynamic response of obstructive
picardial stenosis. Further research found that impairment
f coronary vasoreactivity may appear even before the
evelopment of obstructive lesions and therefore might
erve as an early marker of subclinical atherosclerosis.
revious non-invasive investigations of MBF in relation to
HD risk factors have been mostly conducted in clinical
able 2. Results for Age, Gender, and Race Adjusted Linear
egression Models of Myocardial Perfusion Measurements
PR and Hyperemic MBF, Respectively) With Coronary Heart
isease Risk Factors as Predictors
Risk Factors
Hyperemic
Blood Flow
(ml/min/g)† Perfusion Reserve
* p * p
ge (10.3 yrs),
unadjusted‡
–0.024 0.0001 –0.029 0.0001
en vs. women,
age-adjusted
–0.60 0.0001 –0.24 0.03
ispanic vs. Caucasian,
age-adjusted
–0.032 0.75 –0.056 0.61
urrent smoker vs.
never smoker
–0.0018 0.99 –0.047 0.77
ormer smoker vs.
never smoker
0.11 0.28 0.12 0.31
verweight vs.
normal weight
0.020 0.87 –0.022 0.88
bese vs. normal weight –0.046 0.71 –0.17 0.24
oderate vs. low
physical activity
–0.047 0.69 –0.065 0.64
igh vs. low
physical activity
–0.13 0.33 –0.13 0.38
ypertension vs. no –0.18 0.08 –0.30 0.01
ystolic blood pressure
(18.7 mm Hg)‡
–0.0012 0.66 –0.0034 0.29
iastolic blood pressure
(10.1 mm Hg)‡
–0.0099 0.05 –0.013 0.03
iabetes vs. no –0.036 0.81 –0.12 0.51
asting glucose
(24.0 mg/dl)‡
–0.0009 0.65 –0.0026 0.27
otal cholesterol
(33.7 mg/dl)‡
–0.0028 0.04 –0.0044 0.005
DL cholesterol
(28.4 mg/dl)‡
–0.0025 0.12 –0.0039 0.04
DL cholesterol
(13.5 mg/dl)‡
–0.0038 0.31 –0.0027 0.54
Regression coefficients were estimated by using a separate model for each specific risk
actor, adjusting for age, gender, and race, unless otherwise stated. †Regression
oefficients for hyperemic blood flow also adjusted for resting blood flow. ‡Value inH
arentheses is the standard deviation of the continuous risk factor.
PR  perfusion reserve; other abbreviations as in Table 1.ase-control studies. In agreement with prior work by others
21–25), we observed that resting MBF increases with age
hereas hyperemic MBF and PR decline with age; MBF is
igher in women than in men, both at rest and during
yperemia, even after correction for RPP and adjustment
or age. The significantly higher MBF and PR found in our
emale participants without obstructive CHD remained
ven when menopause status and hormone use were con-
idered, which suggests that the gender difference may not
e completely explained by a direct effect of estrogen. We
lso corroborated other studies (26–28) showing that PR
nduced by endothelium-independent vasodilators was sim-
lar in smokers and non-smokers. Myocardial blood flow
bnormalities were seen in our asymptomatic subjects with
ypertension, which was consistent with earlier findings of
erfusion defects in hypertensive patients with no signifi-
ant CHD (1,2). Besides the increased resting MBF due to
he higher myocardial oxygen consumption (29), hyperten-
ion also increases total coronary vascular resistance (30),
hich further reduces PR. Reductions in stress MBF and
R have been previously reported in both type 1 (3–5) and
ype 2 (4,6,7) diabetes patients in the absence of clinical
HD, attributable to hyperglycemia, hyperinsulinemia and
nsulin resistance, or a pronounced accumulation of other
isk factors. In our study, hyperemic MBF and PR were
elatively lower in diabetic than in non-diabetic participants,
nd fasting blood glucose was inversely correlated with PR.
able 3. Results for Multivariate Adjusted Linear Regression
odels of Myocardial Perfusion Measurements (PR and
yperemic MBF, Respectively) With Coronary Heart Disease
isk Factors as Predictors
Risk Factors
Hyperemic
Blood Flow
(ml/min/g)† Perfusion Reserve
* p * p
urrent smoker vs.
never smoker
0.014 0.92 –0.019 0.90
ormer smoker vs.
never smoker
0.099 0.33 0.10 0.38
verweight vs.
normal weight
–0.0075 0.95 –0.046 0.75
besity vs.
normal weight
–0.067 0.62 –0.17 0.28
oderate vs. low
physical activity
–0.059 0.62 –0.08 0.54
igh vs. low
physical activity
–0.11 0.39 –0.12 0.45
ypertension vs. no –0.18 0.09 –0.28 0.03
iabetes vs. no –0.07 0.67 –0.15 0.40
otal cholesterol
(33.7 mg/dl)‡
–0.0028 0.05 –0.0044 0.006
DL cholesterol
(13.5 mg/dl)‡
–0.0044 0.28 –0.0044 0.34
Regression coefficients were estimated adjusting for all the other variables listed in
he table as well as age, gender, and race. †Regression coefficients for hyperemic blood
ow also adjusted for resting blood flow. ‡Value in parentheses is the standard
eviation of the continuous risk factor.
Abbreviations as in Tables 1 and 2.owever, these associations disappeared when adjusting for
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Coronary Risk Factors and Myocardial Perfusion February 2006:565–72ther risk factors. One of the more persistent associations
e found is for hypercholesterolemia. Compared with
ormocholesterolemic subjects, in subjects with high levels
f total cholesterol or LDL cholesterol, elevated resting
BF combined with decreased hyperemic MBF resulted in
significantly lower PR. Diminished maximal MBF and
R have been seen in patients with familial hypercholester-
lemia but without overt atherosclerosis (8–10). Non-
ignificant atherosclerotic lesions caused by hypercholester-
lemia may increase vessel wall stiffness and weaken the
mooth muscle layer (31). Hypercholesterolemia also causes
ndothelial dysfunction in large conduit vessels, as well as in
esistance vessels (32). High HDL cholesterol did not seem
o ameliorate unfavorable PR.
Compared to previous clinical studies of highly selected
atients, the associations of myocardial perfusion with
ndividual risk factors in our study were generally weak. This
s not surprising, considering that our study subjects were
rom a population with, on average, moderate risk factor
evels. When the overall risk burden was assessed using the
ramingham prediction equations, risk factor burden was
trongly and inversely associated with hyperemic MBF and
R. Moreover, in the current study, the inverse correlations
f hyperemic MBF and PR with systolic blood pressure and
asting glucose level were substantially attenuated and no
onger statistically significant after age adjustment. Such
trong confounding by age was not seen in most other
tudies, probably because those studies usually focused on
he association between MBF and single risk factors, such as
moking, hyperlipidemia, and diabetes mellitus, and com-
ared patients with age- and gender-matched control
roups. Our study population had a broad age range, and
ge demonstrated the strongest risk factor correlation with
igure 1. Myocardial perfusion measurements examined by magnetic
esonance imaging among asymptomatic subjects according to quartiles of
redicted absolute 10-year risk of coronary heart disease (CHD): 1% to
.8% (median: 3%), 4.9% to 7.9% (median: 6%), 8% to 14.9% (median:
1%), 15% to 46% (median: 20%), estimated using Framingham prediction
quations with total cholesterol categories (20). The p values for trend are
 0.004 for rest MBF, and p 0.0001 for hyperemic MBF and PR. The
rror bar represented 95% confidence interval (CI).R; therefore, the remaining effect of other individual risk tactors, independent of age, was relatively small. Finally, few
tudies have addressed MBF in association with obesity and
hysical activity. In our study, greater physical activity or
maller BMI did not relate to higher age-adjusted hyper-
mic MBF and PR.
Perfusion reserve, calculated as the ratio of hyperemic
BF divided by resting MBF, could be reduced by either a
ecrease in the numerator or an elevation in the denomi-
ator, or both. In the scenario of CHD, when the coronary
esistance vessels get sparser, smaller, or less responsive to
asodilatory stimuli, the maximal MBF will be abnormally
ow while resting MBF may remain normal (18). High
esting flow is most likely caused by conditions requiring
ncreased cardiac work and consequently higher myocardial
emand for energy, when compensatory mechanisms, e.g.,
ilation of the distal vascular bed, become involved even at
est. In such cases, the remaining available flow reserve
ight decrease even if the maximal flow attainable does not
iminish. For most risk factors investigated in the present
tudy, the inverse relation with PR resulted primarily from
n inverse relation with hyperemic MBF, combined with a
rend toward a positive relation with resting MBF. Model-
ng PR alternatively as hyperemic MBF with adjustment for
esting MBF yielded similar results (Table 2).
The CMR first-pass technique combined with the
odel-independent deconvolution method used in our
tudy to quantify MBF was previously validated in experi-
ental animal studies by comparison to MBF measure-
ents with radio-isotope labeled microspheres (16), which
s regarded as the reference method for quantification of
BF, although it is not applicable to human studies. The
inear correlation of CMR-estimated MBF against mea-
urements from radio-isotope labeled microspheres was
xcellent (r2  0.995, slope: 0.96, intercept: 0.06). The
eliability of MBF quantification in the current study was
enerally satisfactory. The coefficient of variation of re-
eated measurements in each myocardial sector, performed
ne year apart, averaged 16.7  14.4% (n  13 subjects) for
esting MBF and 16.6  13.3% (n  8 subjects) for
yperemic MBF.
The blood flow response to adenosine is predominantly
licited by relaxation of coronary arteriolar smooth muscle
ells. An endothelium-mediated dilation of the proximal
essels, induced by the increased blood flow, could further
nhance the total vasodilatory response. Considering
therogenesis to have multiple stages offers another expla-
ation for the dose-response relation we observed between
isk factor levels and PR. In some individuals with just mild
o moderate CHD risk factor elevations, selective dysfunc-
ion of endothelium alone may or may not produce an
bnormal vasodilation to adenosine. Among subjects with
more advanced risk profile, a more extensive disorder of
ndothelial cells and smooth muscle cells may further
mpair PR.
Several issues should be considered as potential limita-
ions of the current study. First of all, in this cross-sectional
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ith concurrent PR. The causal effect of a risk factor on the
evelopment of vasoreactivity impairment cannot be estab-
ished. In addition, the prognostic value of risk factor
ssessment versus a measurement of myocardial perfusion
annot be compared at this point because of the lack of
ollow-up data. Secondly, because these asymptomatic par-
icipants did not undergo coronary angiography, some may
ave had obstructive atherosclerotic lesions that were not
etected clinically. Coronary calcification was measured by
omputed tomography in this cohort, but the coronary
alcium burden cannot reliably predict stenosis severity or
he hemodynamic significance of a calcified lesion. For these
easons, it is difficult to infer a direct effect of CHD risk
actors on vascular function, independent of coronary ste-
osis burden. Thirdly, the majority of subjects in this
symptomatic population had a low to medium predicted
0-year CHD risk. Few participants had extraordinarily
dverse risk characteristics. Although our sample size was
oderate, we may not have had sufficient statistical power
o detect some weak but real associations. One also may not
e able to directly generalize our findings from the subgroup
f MESA volunteers who participated in the perfusion
tudy, to the whole MESA population due to differences in
MI and the prevalence of hypertension. Finally, we cannot
ule out the possibility that the hyperemic MBF response
as attenuated by premature stopping of adenosine in
articipants having an AV block, although this concern was
ot borne out by a comparison of MBF measured in subjects
ith versus those without AV block. The high proportion of
atients with AV block is probably secondary to use of the
ame IV line for adenosine and MR contrast. Use of two IV
ines could have avoided this complication. Previous studies
eport that, during intracoronary administration of adeno-
ine in patients, a plateau phase, when the coronary flow
elocity remains within 10% of its peak value, lasts approx-
mately 6 s after stopping the adenosine infusion (33,34).
herefore, we expect that when IV adenosine is not re-
umed after the 3-min initial infusion because of a transient
V block, MBF will stay close to its peak for the initial
yocardial contrast-enhancement, which is sufficiently long
o estimate hyperemic MBF (35).
In conclusion, our study shows that coronary vasoreactiv-
ty is reduced in asymptomatic adults with a greater coro-
ary risk factor burden. With respect to individual risk
actors, age is correlated inversely with the vasodilatory
esponse. High diastolic blood pressure, total cholesterol,
nd LDL cholesterol are associated with lower flow re-
ponse independent of age. These findings corroborate that
unctional changes in coronary vasculature may occur in
symptomatic adults with risk factors, which supports re-
uced vasoreactivity as an indicator of CHD before its
linical manifestation. Our investigations improve the un-
erstanding of the physiology and pathophysiology role of
yocardial perfusion in the process of coronary atheroscle-osis. Findings from this study also provide importantaseline information for future research on the clinical use
f perfusion studies, as well as on the subclinical CHD
valuation.
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